🚀 VC round data is live in beta, check it out!
GH Research Valuation Multiples
Discover revenue and EBITDA valuation multiples for GH Research and similar public comparables like Amphastar Pharma, SPIMACO - ADDWAEIH, Biotest, SSY Group and more.
GH Research Overview
About GH Research
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Founded
2021
HQ
Employees
50
Website
Sectors
Financials (LTM)
EV
$667M
GH Research Financials
GH Research reported last 12-month revenue of — and negative EBITDA of ($67M).
In the same LTM period, GH Research generated — in gross profit, ($67M) in EBITDA losses, and had net loss of ($60M).
Revenue (LTM)
GH Research P&L
In the most recent fiscal year, GH Research reported revenue of — and EBITDA of ($48M).
GH Research expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | ($67M) | XXX | ($48M) | XXX | XXX | XXX |
| Net Profit | ($60M) | XXX | ($48M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
GH Research Stock Performance
GH Research has current market cap of $947M, and enterprise value of $667M.
Market Cap Evolution
GH Research's stock price is $15.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $667M | $947M | 1.9% | XXX | XXX | XXX | $-0.78 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGH Research Valuation Multiples
GH Research trades at (9.9x) EV/EBITDA.
GH Research Financial Valuation Multiples
As of April 11, 2026, GH Research has market cap of $947M and EV of $667M.
Equity research analysts estimate GH Research's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
GH Research has a P/E ratio of (15.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $947M | XXX | $947M | XXX | XXX | XXX |
| EV (current) | $667M | XXX | $667M | XXX | XXX | XXX |
| EV/EBITDA | (9.9x) | XXX | (13.9x) | XXX | XXX | XXX |
| EV/EBIT | (8.9x) | XXX | (11.1x) | XXX | XXX | XXX |
| P/E | (15.8x) | XXX | (19.7x) | XXX | XXX | XXX |
| EV/FCF | (12.8x) | XXX | (15.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified GH Research Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
GH Research Margins & Growth Rates
GH Research's revenue in the last fiscal year grew by —.
GH Research's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.
GH Research Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | 40% | XXX | 78% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
GH Research Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Amphastar Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| SPIMACO - ADDWAEIH | XXX | XXX | XXX | XXX | XXX | XXX |
| Biotest | XXX | XXX | XXX | XXX | XXX | XXX |
| SSY Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Center Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GH Research M&A Activity
GH Research acquired XXX companies to date.
Last acquisition by GH Research was on XXXXXXXX, XXXXX. GH Research acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by GH Research
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGH Research Investment Activity
GH Research invested in XXX companies to date.
GH Research made its latest investment on XXXXXXXX, XXXXX. GH Research invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by GH Research
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout GH Research
| When was GH Research founded? | GH Research was founded in 2021. |
| Where is GH Research headquartered? | GH Research is headquartered in Ireland. |
| How many employees does GH Research have? | As of today, GH Research has over 50 employees. |
| Who is the CEO of GH Research? | GH Research's CEO is Velichka Valcheva. |
| Is GH Research publicly listed? | Yes, GH Research is a public company listed on Nasdaq. |
| What is the stock symbol of GH Research? | GH Research trades under GHRS ticker. |
| When did GH Research go public? | GH Research went public in 2021. |
| Who are competitors of GH Research? | GH Research main competitors are Amphastar Pharma, SPIMACO - ADDWAEIH, Biotest, SSY Group. |
| What is the current market cap of GH Research? | GH Research's current market cap is $947M. |
| Is GH Research profitable? | No, GH Research is not profitable. |
| What is the current EBITDA of GH Research? | GH Research has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of GH Research? | Current EBITDA multiple of GH Research is (9.9x). |
| What is the current FCF of GH Research? | GH Research's last 12 months FCF is ($52M). |
| What is the current EV/FCF multiple of GH Research? | Current FCF multiple of GH Research is (12.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.